An international consortium, including Dr. Florian A. Wenzl from the CMC, has published new insights in The Lancet Respiratory Medicine on optimising trial design for the personalised management of cardiogenic shock. The article highlights the potential of artificial intelligence and circulating biomarkers as key tools to advance precision care in this critical condition.

Learn more about this Position Paper (Lancet Respir Med. 2025 May 5) here!